GO:0051179 | localization | 16.82% (18/107) | 1.67 | 1.3e-05 | 0.000534 |
GO:0009141 | nucleoside triphosphate metabolic process | 4.67% (5/107) | 4.07 | 1.3e-05 | 0.000584 |
GO:0051234 | establishment of localization | 16.82% (18/107) | 1.67 | 1.2e-05 | 0.000612 |
GO:0006810 | transport | 16.82% (18/107) | 1.67 | 1.2e-05 | 0.000612 |
GO:0015291 | secondary active transmembrane transporter activity | 5.61% (6/107) | 3.6 | 1.1e-05 | 0.000712 |
GO:0015297 | antiporter activity | 5.61% (6/107) | 3.62 | 1e-05 | 0.000775 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 4.67% (5/107) | 3.85 | 2.6e-05 | 0.000799 |
GO:0009123 | nucleoside monophosphate metabolic process | 4.67% (5/107) | 3.85 | 2.6e-05 | 0.000799 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 4.67% (5/107) | 3.85 | 2.6e-05 | 0.000799 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 4.67% (5/107) | 3.85 | 2.6e-05 | 0.000799 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 4.67% (5/107) | 4.16 | 1e-05 | 0.000864 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 4.67% (5/107) | 4.16 | 1e-05 | 0.000864 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 4.67% (5/107) | 4.16 | 1e-05 | 0.000864 |
GO:0015238 | drug transmembrane transporter activity | 5.61% (6/107) | 4.03 | 2e-06 | 0.000886 |
GO:0019637 | organophosphate metabolic process | 5.61% (6/107) | 3.27 | 3.9e-05 | 0.00111 |
GO:0071705 | nitrogen compound transport | 6.54% (7/107) | 2.88 | 4.9e-05 | 0.001237 |
GO:0071702 | organic substance transport | 6.54% (7/107) | 2.81 | 6.7e-05 | 0.001263 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4.67% (5/107) | 3.68 | 4.7e-05 | 0.001263 |
GO:0022804 | active transmembrane transporter activity | 6.54% (7/107) | 2.84 | 5.9e-05 | 0.001264 |
GO:0019693 | ribose phosphate metabolic process | 4.67% (5/107) | 3.58 | 6.5e-05 | 0.001281 |
GO:0009150 | purine ribonucleotide metabolic process | 4.67% (5/107) | 3.62 | 5.7e-05 | 0.001283 |
GO:0009259 | ribonucleotide metabolic process | 4.67% (5/107) | 3.62 | 5.7e-05 | 0.001283 |
GO:0006163 | purine nucleotide metabolic process | 4.67% (5/107) | 3.59 | 6.3e-05 | 0.001294 |
GO:0072521 | purine-containing compound metabolic process | 4.67% (5/107) | 3.53 | 7.7e-05 | 0.001391 |
GO:0009117 | nucleotide metabolic process | 4.67% (5/107) | 3.49 | 8.7e-05 | 0.001521 |
GO:0005471 | ATP:ADP antiporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0015605 | organophosphate ester transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0015217 | ADP transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0008514 | organic anion transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0015215 | nucleotide transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0006862 | nucleotide transport | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0005346 | purine ribonucleotide transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0005347 | ATP transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0000295 | adenine nucleotide transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0015748 | organophosphate ester transport | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0015301 | anion:anion antiporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0015216 | purine nucleotide transmembrane transporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:0099516 | ion antiporter activity | 2.8% (3/107) | 4.85 | 0.000157 | 0.00155 |
GO:1901135 | carbohydrate derivative metabolic process | 5.61% (6/107) | 2.9 | 0.000161 | 0.001553 |
GO:0090407 | organophosphate biosynthetic process | 4.67% (5/107) | 3.47 | 9.3e-05 | 0.00156 |
GO:0006753 | nucleoside phosphate metabolic process | 4.67% (5/107) | 3.44 | 0.000105 | 0.001701 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 3.74% (4/107) | 3.95 | 0.000138 | 0.001888 |
GO:0006754 | ATP biosynthetic process | 3.74% (4/107) | 3.95 | 0.000138 | 0.001888 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 3.74% (4/107) | 3.95 | 0.000138 | 0.001888 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.74% (4/107) | 3.95 | 0.000138 | 0.001888 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 3.74% (4/107) | 3.95 | 0.000138 | 0.001888 |
GO:0046034 | ATP metabolic process | 4.67% (5/107) | 4.17 | 9e-06 | 0.002051 |
GO:0016872 | intramolecular lyase activity | 1.87% (2/107) | 6.39 | 0.000244 | 0.002084 |
GO:0019200 | carbohydrate kinase activity | 1.87% (2/107) | 6.39 | 0.000244 | 0.002084 |
GO:0008443 | phosphofructokinase activity | 1.87% (2/107) | 6.39 | 0.000244 | 0.002084 |
GO:0003872 | 6-phosphofructokinase activity | 1.87% (2/107) | 6.39 | 0.000244 | 0.002084 |
GO:0015932 | nucleobase-containing compound transmembrane transporter activity | 2.8% (3/107) | 4.65 | 0.000235 | 0.002173 |
GO:1901505 | carbohydrate derivative transmembrane transporter activity | 2.8% (3/107) | 4.65 | 0.000235 | 0.002173 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.67% (5/107) | 3.13 | 0.000278 | 0.002331 |
GO:0015931 | nucleobase-containing compound transport | 2.8% (3/107) | 4.55 | 0.000292 | 0.002403 |
GO:0005575 | cellular_component | 22.43% (24/107) | 1.08 | 0.00031 | 0.002504 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 3.74% (4/107) | 3.61 | 0.000338 | 0.002556 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 3.74% (4/107) | 3.61 | 0.000338 | 0.002556 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 3.74% (4/107) | 3.61 | 0.000338 | 0.002556 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 3.74% (4/107) | 3.61 | 0.000338 | 0.002556 |
GO:0009260 | ribonucleotide biosynthetic process | 3.74% (4/107) | 3.58 | 0.000362 | 0.002607 |
GO:0046390 | ribose phosphate biosynthetic process | 3.74% (4/107) | 3.58 | 0.000362 | 0.002607 |
GO:0009152 | purine ribonucleotide biosynthetic process | 3.74% (4/107) | 3.58 | 0.000362 | 0.002607 |
GO:0006164 | purine nucleotide biosynthetic process | 3.74% (4/107) | 3.54 | 0.000401 | 0.002837 |
GO:0044425 | membrane part | 10.28% (11/107) | 1.73 | 0.000489 | 0.003357 |
GO:0072522 | purine-containing compound biosynthetic process | 3.74% (4/107) | 3.47 | 0.000486 | 0.003385 |
GO:0009165 | nucleotide biosynthetic process | 3.74% (4/107) | 3.45 | 0.000517 | 0.003442 |
GO:1901293 | nucleoside phosphate biosynthetic process | 3.74% (4/107) | 3.45 | 0.000517 | 0.003442 |
GO:0017144 | drug metabolic process | 4.67% (5/107) | 2.88 | 0.000623 | 0.004089 |
GO:0046939 | nucleotide phosphorylation | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0046031 | ADP metabolic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0042866 | pyruvate biosynthetic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0009132 | nucleoside diphosphate metabolic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0006096 | glycolytic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0006165 | nucleoside diphosphate phosphorylation | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0006757 | ATP generation from ADP | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0009135 | purine nucleoside diphosphate metabolic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0009166 | nucleotide catabolic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 2.8% (3/107) | 3.97 | 0.000941 | 0.005329 |
GO:0006090 | pyruvate metabolic process | 2.8% (3/107) | 3.91 | 0.001075 | 0.006013 |
GO:0019363 | pyridine nucleotide biosynthetic process | 2.8% (3/107) | 3.87 | 0.001171 | 0.00639 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 2.8% (3/107) | 3.87 | 0.001171 | 0.00639 |
GO:1901292 | nucleoside phosphate catabolic process | 2.8% (3/107) | 3.85 | 0.001221 | 0.006505 |
GO:0072525 | pyridine-containing compound biosynthetic process | 2.8% (3/107) | 3.85 | 0.001221 | 0.006505 |
GO:0046496 | nicotinamide nucleotide metabolic process | 2.8% (3/107) | 3.82 | 0.001272 | 0.006622 |
GO:0019362 | pyridine nucleotide metabolic process | 2.8% (3/107) | 3.82 | 0.001272 | 0.006622 |
GO:0072524 | pyridine-containing compound metabolic process | 2.8% (3/107) | 3.8 | 0.001324 | 0.00674 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 2.8% (3/107) | 3.8 | 0.001324 | 0.00674 |
GO:0046434 | organophosphate catabolic process | 2.8% (3/107) | 3.76 | 0.001433 | 0.007213 |
GO:0008509 | anion transmembrane transporter activity | 2.8% (3/107) | 3.75 | 0.00149 | 0.007415 |
GO:0055085 | transmembrane transport | 10.28% (11/107) | 1.53 | 0.001552 | 0.007641 |
GO:0022857 | transmembrane transporter activity | 10.28% (11/107) | 1.51 | 0.001743 | 0.008488 |
GO:0019438 | aromatic compound biosynthetic process | 4.67% (5/107) | 2.52 | 0.001893 | 0.009124 |
GO:0005215 | transporter activity | 10.28% (11/107) | 1.48 | 0.001964 | 0.009265 |
GO:0016021 | integral component of membrane | 8.41% (9/107) | 1.69 | 0.001951 | 0.009304 |
GO:0031224 | intrinsic component of membrane | 8.41% (9/107) | 1.68 | 0.002067 | 0.009651 |
GO:0006855 | drug transmembrane transport | 2.8% (3/107) | 3.51 | 0.002354 | 0.010771 |
GO:0015893 | drug transport | 2.8% (3/107) | 3.51 | 0.002354 | 0.010771 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 2.8% (3/107) | 3.47 | 0.002589 | 0.011729 |
GO:1901566 | organonitrogen compound biosynthetic process | 6.54% (7/107) | 1.92 | 0.002618 | 0.011744 |
GO:0004107 | chorismate synthase activity | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0072655 | establishment of protein localization to mitochondrion | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0070585 | protein localization to mitochondrion | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0030150 | protein import into mitochondrial matrix | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0005744 | TIM23 mitochondrial import inner membrane translocase complex | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0006839 | mitochondrial transport | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:1990542 | mitochondrial transmembrane transport | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0071806 | protein transmembrane transport | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0044743 | protein transmembrane import into intracellular organelle | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0065002 | intracellular protein transmembrane transport | 0.93% (1/107) | 8.39 | 0.002982 | 0.011955 |
GO:0009108 | coenzyme biosynthetic process | 2.8% (3/107) | 3.44 | 0.002754 | 0.01223 |
GO:0006091 | generation of precursor metabolites and energy | 2.8% (3/107) | 3.42 | 0.002838 | 0.012483 |
GO:0034655 | nucleobase-containing compound catabolic process | 2.8% (3/107) | 3.36 | 0.003193 | 0.012688 |
GO:0019439 | aromatic compound catabolic process | 2.8% (3/107) | 3.29 | 0.003673 | 0.013983 |
GO:0046700 | heterocycle catabolic process | 2.8% (3/107) | 3.29 | 0.003673 | 0.013983 |
GO:0044270 | cellular nitrogen compound catabolic process | 2.8% (3/107) | 3.29 | 0.003673 | 0.013983 |
GO:1901361 | organic cyclic compound catabolic process | 2.8% (3/107) | 3.29 | 0.003673 | 0.013983 |
GO:0016053 | organic acid biosynthetic process | 3.74% (4/107) | 2.67 | 0.003741 | 0.014006 |
GO:0046394 | carboxylic acid biosynthetic process | 3.74% (4/107) | 2.67 | 0.003741 | 0.014006 |
GO:0051188 | cofactor biosynthetic process | 2.8% (3/107) | 3.27 | 0.003774 | 0.014014 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.67% (5/107) | 2.3 | 0.003587 | 0.014128 |
GO:0006732 | coenzyme metabolic process | 2.8% (3/107) | 3.19 | 0.004416 | 0.016262 |
GO:0072330 | monocarboxylic acid biosynthetic process | 2.8% (3/107) | 3.18 | 0.004528 | 0.016544 |
GO:0045184 | establishment of protein localization | 3.74% (4/107) | 2.56 | 0.004919 | 0.01714 |
GO:0015031 | protein transport | 3.74% (4/107) | 2.56 | 0.004919 | 0.01714 |
GO:0015833 | peptide transport | 3.74% (4/107) | 2.56 | 0.004919 | 0.01714 |
GO:0008104 | protein localization | 3.74% (4/107) | 2.56 | 0.004919 | 0.01714 |
GO:0033036 | macromolecule localization | 3.74% (4/107) | 2.56 | 0.004919 | 0.01714 |
GO:0042886 | amide transport | 3.74% (4/107) | 2.56 | 0.004919 | 0.01714 |
GO:0016052 | carbohydrate catabolic process | 2.8% (3/107) | 3.13 | 0.004998 | 0.017282 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3.74% (4/107) | 2.51 | 0.00555 | 0.019047 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 0.93% (1/107) | 7.39 | 0.005956 | 0.019409 |
GO:0015629 | actin cytoskeleton | 0.93% (1/107) | 7.39 | 0.005956 | 0.019409 |
GO:0008198 | ferrous iron binding | 0.93% (1/107) | 7.39 | 0.005956 | 0.019409 |
GO:0030118 | clathrin coat | 0.93% (1/107) | 7.39 | 0.005956 | 0.019409 |
GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity | 0.93% (1/107) | 7.39 | 0.005956 | 0.019409 |
GO:0030132 | clathrin coat of coated pit | 0.93% (1/107) | 7.39 | 0.005956 | 0.019409 |
GO:0030125 | clathrin vesicle coat | 0.93% (1/107) | 7.39 | 0.005956 | 0.019409 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.8% (3/107) | 3.02 | 0.006157 | 0.019923 |
GO:0006725 | cellular aromatic compound metabolic process | 7.48% (8/107) | 1.55 | 0.006324 | 0.020316 |
GO:0098771 | inorganic ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0010638 | positive regulation of organelle organization | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0045010 | actin nucleation | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0055082 | cellular chemical homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0055080 | cation homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0055076 | transition metal ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0007015 | actin filament organization | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0005885 | Arp2/3 protein complex | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0032273 | positive regulation of protein polymerization | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0031334 | positive regulation of protein complex assembly | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0044089 | positive regulation of cellular component biogenesis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0030838 | positive regulation of actin filament polymerization | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0051495 | positive regulation of cytoskeleton organization | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0055072 | iron ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0055065 | metal ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0008199 | ferric iron binding | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:1902905 | positive regulation of supramolecular fiber organization | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0006376 | mRNA splice site selection | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0006879 | cellular iron ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0005685 | U1 snRNP | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0097435 | supramolecular fiber organization | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0006873 | cellular ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0006875 | cellular metal ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0050801 | ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0048878 | chemical homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0046916 | cellular transition metal ion homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0030003 | cellular cation homeostasis | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0003855 | 3-dehydroquinate dehydratase activity | 0.93% (1/107) | 6.8 | 0.00892 | 0.023493 |
GO:0034622 | cellular protein-containing complex assembly | 1.87% (2/107) | 3.8 | 0.009088 | 0.023798 |
GO:0098660 | inorganic ion transmembrane transport | 2.8% (3/107) | 2.8 | 0.00927 | 0.023861 |
GO:0098655 | cation transmembrane transport | 2.8% (3/107) | 2.8 | 0.00927 | 0.023861 |
GO:0098662 | inorganic cation transmembrane transport | 2.8% (3/107) | 2.8 | 0.00927 | 0.023861 |
GO:0015672 | monovalent inorganic cation transport | 2.8% (3/107) | 2.78 | 0.009624 | 0.024492 |
GO:0034220 | ion transmembrane transport | 2.8% (3/107) | 2.78 | 0.009624 | 0.024492 |
GO:0032787 | monocarboxylic acid metabolic process | 2.8% (3/107) | 2.76 | 0.009985 | 0.025269 |
GO:0016853 | isomerase activity | 2.8% (3/107) | 2.76 | 0.010168 | 0.02559 |
GO:0044283 | small molecule biosynthetic process | 3.74% (4/107) | 2.35 | 0.008182 | 0.0261 |
GO:0051186 | cofactor metabolic process | 2.8% (3/107) | 2.74 | 0.010541 | 0.026236 |
GO:0018130 | heterocycle biosynthetic process | 3.74% (4/107) | 2.24 | 0.010492 | 0.026259 |
GO:0065003 | protein-containing complex assembly | 1.87% (2/107) | 3.66 | 0.010996 | 0.02722 |
GO:0015075 | ion transmembrane transporter activity | 4.67% (5/107) | 1.99 | 0.00878 | 0.027815 |
GO:1902600 | proton transmembrane transport | 1.87% (2/107) | 3.63 | 0.011397 | 0.028059 |
GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity | 0.93% (1/107) | 6.39 | 0.011876 | 0.028464 |
GO:0004470 | malic enzyme activity | 0.93% (1/107) | 6.39 | 0.011876 | 0.028464 |
GO:0016615 | malate dehydrogenase activity | 0.93% (1/107) | 6.39 | 0.011876 | 0.028464 |
GO:0004764 | shikimate 3-dehydrogenase (NADP+) activity | 0.93% (1/107) | 6.39 | 0.011876 | 0.028464 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 5.61% (6/107) | 1.67 | 0.011799 | 0.028891 |
GO:0043933 | protein-containing complex subunit organization | 1.87% (2/107) | 3.58 | 0.012218 | 0.02913 |
GO:0044281 | small molecule metabolic process | 5.61% (6/107) | 1.63 | 0.013208 | 0.031325 |
GO:0003729 | mRNA binding | 0.93% (1/107) | 6.07 | 0.014823 | 0.034792 |
GO:0005856 | cytoskeleton | 0.93% (1/107) | 6.07 | 0.014823 | 0.034792 |
GO:0022618 | ribonucleoprotein complex assembly | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:1902903 | regulation of supramolecular fiber organization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0051493 | regulation of cytoskeleton organization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0090066 | regulation of anatomical structure size | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0110053 | regulation of actin filament organization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0032970 | regulation of actin filament-based process | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0044087 | regulation of cellular component biogenesis | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0030833 | regulation of actin filament polymerization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0032271 | regulation of protein polymerization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0030832 | regulation of actin filament length | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0008064 | regulation of actin polymerization or depolymerization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0032535 | regulation of cellular component size | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0032956 | regulation of actin cytoskeleton organization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0071826 | ribonucleoprotein complex subunit organization | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0043254 | regulation of protein complex assembly | 0.93% (1/107) | 5.8 | 0.017761 | 0.038682 |
GO:0009058 | biosynthetic process | 8.41% (9/107) | 1.18 | 0.017917 | 0.038836 |
GO:0044249 | cellular biosynthetic process | 7.48% (8/107) | 1.25 | 0.019948 | 0.043031 |
GO:0006886 | intracellular protein transport | 2.8% (3/107) | 2.37 | 0.02049 | 0.04399 |
GO:0022607 | cellular component assembly | 1.87% (2/107) | 3.18 | 0.020699 | 0.044021 |
GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism | 0.93% (1/107) | 5.58 | 0.020691 | 0.044212 |